Gendiagnostik SA, beneficiary from Senacyt financing

This year, Gendiagnostik start two projects, partially sponsored by the SENACYT, which will allow help to improve the quality of life of the population. The first project, led by Dr. Oriana Batista, is supported by the business innovation program and it will facilitate the establishment of new genetic services. The second project, led by Dr. Virginia Nunez, and favored by the new research program entitled: Molecular epidemiology of Neisseria gonorrhoeae involved in sexually transmitted infections.

La mutación G202A, en hijo hemicigoto (arriba) y madre heterocigota (abajo). Esta mutación acompañada de la mutación A376G ó T968C definen la variante africana negativa.

×

Arriba se muestra el resultado de un niño hemicigoto para la variante africana negativa, caracterizada por las mutaciones A376G y G202A, y abajo de una niña heterocigota para la variante Mediterránea, definida por la mutación C563T.

×

The G202A mutation, in the hemizygous son (above) and heterozygous mother (below). This
mutation accompanied with the A376G mutation or T968C define the african negative variant.

×

Above the result of a hemizygous child with the african negative variant , characterized by
mutations A376G and G202A , and below a heterozygous girl with the mediterranean variant, defined by the C563T mutation

×